Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8<sup>+</sup> T Cell Responses via CD169<sup>+</sup> Macrophages and cDC1.

Vaccines (Basel) · 2021 · PMC7830461 · PMID 33467048

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

near-significantno p-value reported

Where p values were near-significant, exact values were provided. 3.

also in 2,306 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.